Springworks Therapeutics Inc (SWTX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Springworks Therapeutics Inc   (NASDAQ: SWTX)

Springworks Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information




SWTX Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 0 % 78.84 % 67.54 % 46.73 %
Gross Margin (Q1 TTM) 81.5 % 77.76 % 67.11 % 46.34 %
Gross Profit Margin 5 Yr. Avg. - 71.58 % 65.27 % 47.54 %
EBITDA Margin (Q1 MRQ) 2.24 % 12.9 % 20.82 % 17.71 %
EBITDA Margin (Q1 TTM) -115.76 % 12.17 % 18.45 % 18.14 %
EBITDA Margin 5 Yr. Avg. - 21.56 % 26 % 21.94 %
Operating Margin (Q1 MRQ) 0 % 5.55 % 16.91 % 16.06 %
Operating Margin (Q1 TTM) -126.61 % 3.04 % 15.06 % 15.44 %
Operating Margin 5 Yr. Avg. - 6.78 % 13.31 % 16.97 %
Pre-Tax Profit Margin (Q1 MRQ) 0 % 4.01 % 13.6 % 12.11 %
Pre-Tax Profit Margin (Q1 TTM) -117.51 % 2.86 % 10.15 % 11.84 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.43 % 9.87 % 11.9 %
Net Margin (Q1 MRQ) 0 % -0.01 % 10.49 % 9.67 %
Net Margin (Q1 TTM) -117.51 % 0.34 % 8.88 % 9.55 %
Net Margin 5 Yr. Avg. - 5.82 % 7.17 % 9.59 %



Business Segment Profit Margin
 
Developing and Commercializing Life Changing Medicines
  Explore Developing and Commercializing Life Changing Medicines Segment  -